Tirzepatide NEW

What is Tirzepatide  ?

Tirzepatide is a new dual-receptor channel agonist for glucagon-like peptide-1 receptor (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP, also known as gastric inhibitory peptide). Administer once a week. Both GLP-1 and GIP are incretins, polypeptides secreted by the human gastrointestinal mucosa. The former can bind to receptors on pancreatic islet cells , thus producing a hypoglycemic effect and delaying gastric excretion. Empty and suppress appetite, thereby controlling weight; while the latter has the functions of inhibiting gastric acid and pepsin secretion,, inhibiting gastric motility and emptying, and can supplement the GLP-1 receptor agonist effect.